To unlock this feature and to subscribe to our weekly evidence emails, please create a FREE orthoEvidence account.

SIGNUP

Already Have an Account?

Loading...
Visit our Evidence-Based Covid-19 Website and Stay Up to Date with the latest Research.
Ace Report Cover

Comparison of Total Blood Loss Between Limited Tourniquet Use and Conventional Tourniquet Use in TKA

Share
Reprints
Cite This
About
+ Favorites
Share
Reprints
Cite This
About
+ Favorites
Ace Report Cover
February 2025

Comparison of Total Blood Loss Between Limited Tourniquet Use and Conventional Tourniquet Use in TKA

Vol: 307| Issue: 2| Number:62| ISSN#: 2564-2537
Study Type:Therapy
OE Level Evidence:1
Journal Level of Evidence:1

Comparison of total blood loss between limited tourniquet use and conventional tourniquet use in total knee arthroplasty: a randomized controlled trial.

BMC Musculoskelet Disord . 2024 Nov 15;25(1):918.

Contributing Authors:
P Chaiyakit P Kabkaew N Hongku P Wattanapreechanon

Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here

Synopsis

Ninety patients undergoing unilateral primary TKA were randomized to receive either limited tourniquet use (LIM-TKA, n=45) or conventional tourniquet use (CON-TKA, n=45). The primary outcome of interest was total blood loss. Secondary outcomes included the need for blood transfusion, wound grading scores, incidence of venous thromboembolism (VTE), length of hospital stay, and reoperation rates. Ou...

CME Image

Did you know that you’re eligible to earn 0.5 CME credits for reading this report!

LEARN MORE

Join the Conversation

Please Login or Join to leave comments.

Learn about our AI Driven
High Impact Search Feature

High Impact Icon

Our AI driven High Impact metric calculates the impact an article will have by considering both the publishing journal and the content of the article itself. Built using the latest advances in natural language processing, OE High Impact predicts an article’s future number of citations better than impact factor alone.

Continue